ARTICLE | Clinical News
Ampligen rintatolimod regulatory update
July 23, 2012 7:00 AM UTC
Hemispherx submitted an NDA to Argentina's National Administration of Drugs, Foods and Medical Technology (ANMAT) for Ampligen to treat chronic fatigue syndrome (CFS). The company is also requesting O...